A detailed history of Manufacturers Life Insurance Company, The transactions in Alkermes Plc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 195,743 shares of ALKS stock, worth $5.82 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
195,743
Previous 201,591 2.9%
Holding current value
$5.82 Million
Previous $4.86 Million 12.76%
% of portfolio
0.01%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$23.01 - $28.55 $134,562 - $166,960
-5,848 Reduced 2.9%
195,743 $5.48 Million
Q2 2024

Aug 14, 2024

SELL
$23.21 - $27.24 $176,187 - $206,778
-7,591 Reduced 3.63%
201,591 $4.86 Million
Q1 2024

May 14, 2024

BUY
$26.4 - $32.56 $2.34 Million - $2.89 Million
88,691 Added 73.61%
209,182 $5.66 Million
Q4 2023

Feb 13, 2024

BUY
$23.37 - $28.68 $179,037 - $219,717
7,661 Added 6.79%
120,491 $3.34 Million
Q3 2023

Nov 15, 2023

BUY
$27.17 - $31.97 $1.23 Million - $1.45 Million
45,298 Added 67.08%
112,830 $3.16 Million
Q2 2023

Aug 11, 2023

BUY
$28.34 - $33.63 $43,048 - $51,083
1,519 Added 2.3%
67,532 $2.11 Million
Q1 2023

May 15, 2023

BUY
$25.31 - $29.02 $6,428 - $7,371
254 Added 0.38%
66,267 $1.87 Million
Q4 2022

Aug 11, 2023

BUY
$21.94 - $26.24 $23,146 - $27,683
1,055 Added 1.62%
66,013 $1.72 Million
Q4 2022

Feb 13, 2023

BUY
$21.94 - $26.24 $23,146 - $27,683
1,055 Added 1.62%
66,013 $1.72 Million
Q3 2022

Aug 11, 2023

SELL
$22.0 - $31.87 $21,406 - $31,009
-973 Reduced 1.48%
64,958 $1.45 Million
Q3 2022

Nov 03, 2022

SELL
$22.0 - $31.87 $21,406 - $31,009
-973 Reduced 1.48%
64,958 $1.45 Million
Q2 2022

Aug 11, 2023

SELL
$26.4 - $30.54 $309,328 - $357,837
-11,717 Reduced 15.09%
65,931 $1.96 Million
Q2 2022

Aug 15, 2022

SELL
$26.4 - $30.54 $309,328 - $357,837
-11,717 Reduced 15.09%
65,931 $1.96 Million
Q1 2022

Aug 11, 2023

BUY
$23.07 - $27.99 $262,559 - $318,554
11,381 Added 17.17%
77,648 $2.04 Million
Q1 2022

May 20, 2022

SELL
$23.07 - $27.99 $78,553 - $95,305
-3,405 Reduced 4.2%
77,648 $2.05 Million
Q4 2021

Feb 16, 2022

SELL
$21.47 - $32.08 $27,653 - $41,319
-1,288 Reduced 1.56%
81,053 $1.89 Million
Q3 2021

Nov 12, 2021

SELL
$23.37 - $32.13 $180,322 - $247,915
-7,716 Reduced 8.57%
82,341 $2.54 Million
Q2 2021

Aug 12, 2021

BUY
$18.78 - $25.15 $1.69 Million - $2.26 Million
90,057 New
90,057 $2.21 Million
Q3 2018

Nov 14, 2018

SELL
$38.6 - $46.12 $200,874 - $240,008
-5,204 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$40.56 - $51.36 $6,165 - $7,806
-152 Reduced 2.84%
5,204 $214,000
Q1 2018

May 15, 2018

SELL
$53.61 - $67.26 $10,561 - $13,250
-197 Reduced 3.55%
5,356 $311,000
Q4 2017

Feb 08, 2018

SELL
$47.69 - $55.39 $14,497 - $16,838
-304 Reduced 5.19%
5,553 $304,000
Q3 2017

Nov 14, 2017

BUY
$49.16 - $54.45 $287,930 - $318,913
5,857
5,857 $298,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.88B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.